Artificial intelligence may soon play a critical role in choosing which depression therapy is best for patients.
A national trial initiated by UT Southwestern in 2011 to better understand mood disorders has produced what scientists are calling the project’s flagship finding: a computer that can accurately predict whether an antidepressant will work based on a patient’s brain activity.
The new research is the latest among several studies from the trial that cumulatively show how high-tech strategies can help doctors objectively diagnose and prescribe depression treatments. Although implementing these approaches will take time, researchers predict tools such as AI, brain imaging, and blood tests will revolutionize the field of psychiatry in the coming years.
“These studies have been a bigger success than anyone on our team could have imagined,” says Madhukar Trivedi, M.D., a UT Southwestern psychiatrist who oversaw the multi-site trial involving Stanford, Harvard and other institutions. “We provided abundant data to show we can move past the guessing game of choosing depression treatments and alter the mindset of how the disease should be diagnosed and treated.”
EEG-based predictions
The study published in Nature Biotechnology included more than 300 participants with depression who were randomly chosen to receive either a placebo or an SSRI (selective serotonin reuptake inhibitor), the most common class of antidepressant. Researchers used an electroencephalogram, or EEG, to measure electrical activity in the participants’ cortex before they began treatment. The team then developed a machine-learning algorithm to analyze and use the EEG data to predict which patients would benefit from the medication within two months.
Not only did the AI accurately predict outcomes, further research suggested that patients who were doubtful to respond to an antidepressant were likely to improve with other interventions such as psychotherapy or brain stimulation.
The findings were validated in three additional patient groups.
“This study takes previous research, showing that we can predict who benefits from an antidepressant, and actually brings it to the point of practical utility,” says Amit Etkin, M.D., Ph.D., a Stanford University psychiatry professor who worked with Trivedi to develop the algorithm.
Among the next steps, researchers say, is developing an AI interface that can be widely integrated with EEGs across the country, as well as seeking approval from the U.S. Food and Drug Administration.
Signatures of depression
Data from the study derive from the 16-week EMBARC trial, which Trivedi initiated at four U.S. sites to establish biology-based, objective strategies to remedy mood disorders.
The project evaluated patients with major depressive disorder through brain imaging and various DNA, blood, and other tests. His goal was to address a troubling finding from another study he led (STAR*D) that found up to two-thirds of patients do not adequately respond to their first antidepressant.
“We went into this thinking, ‘Wouldn’t it be better to identify at the beginning of treatment which treatments would be best for which patients?'” Trivedi explains.
Previous EMBARC studies identified various predictive tests, including the use of magnetic resonance imaging (MRI) to examine brain activity in both a resting state and during the processing of emotions. EEG will likely be the most commonly used tool, Trivedi says, because it’s less expensive and – in most cases – will be equally or more effective.
However, a blood test or MRI may be needed for some patients if the depression is manifesting itself in a different way.
“There are many signatures of depression in the body,” Trivedi says. “Having all these tests available will improve the chances of choosing the right treatment the first time.”
Growing problem
According to data from the National Health and Nutrition Examination Survey, antidepressant use in the U.S. has increased nearly 65% over a decade and a half – from 7.7% in 1999-2002 to 12.7% in 2011-2014. Trivedi says the expanded use of medications makes it more critical to further understand the underpinnings of depression and ensure patients are prescribed an effective therapy.
While his team continues to evaluate data from the EMBARC trial, Trivedi has initiated other large research projects to help improve the remission rate of depression. Among them is D2K, a study that will enroll 2,500 patients with depression and bipolar disorders and follow them for 20 years. In addition, RAD is a 10-year study of 2,500 participants (ages 10-24) that will uncover factors for reducing the risk of developing mood or anxiety disorders.
Utilizing some of these enrollees, Trivedi’s research team will study the results from several other tests to assess patients’ biological signatures to determine the most effective treatment.
“It can be devastating for a patient when an antidepressant doesn’t work,” Trivedi says. “Our research is showing that they no longer have to endure the painful process of trial and error.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Depression
- How to shine through seasonal depression | Editorial
According to Healthline, you should strive to receive 10 to 30 minutes of direct sunlight a day, and potentially more depending on how melanated your skin is, which affects how easily it can absorb ...
- ECU Health expert discusses depression during the holidays, what causes it
However, for some coping with loss and depression, it becomes the hardest. WNCT's Gabby Sartori speaks with an ECU Behavioral Health expert to find out more about this and what steps can be taken if ...
- People on meds for depression are showing fewer cases of cancer. Is there a link?
Start the day smarter. Get all the news you need in your inbox each morning. And when surgeons like Ed Steger's slice out tumors, they often find nerves running through the middle or ...
- Seasonal depression: ways to combat, overcome during winter months
Over my last year and a half at college, it has become increasingly obvious to me just how big of a problem seasonal depression is to full time college students.
- Bubba Wallace hit by depression following best friend Ryan Blaney's NASCAR championship
It was 3:42 a.m. in North Carolina as Bubba Wallace's best friend celebrated winning his first NASCAR championship across the country in Arizona. Wallace could have stuck around and partied with Ryan ...
Go deeper with Google Headlines on:
Depression
[google_news title=”” keyword=”depression” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Predicting depression patient outcomes
- Potential biomarkers for predicting immune response and outcomes in lung cancer patients undergoing thermal ablation
This review provides a comprehensive overview of the current state of research on potential biomarkers for predicting immune response and outcomes in lung cancer patients undergoing thermal ablation, ...
- Artificial Intelligence May Predict Ovarian Cancer Therapy Outcomes
IRON, an artificial intelligence model, has an 80% accuracy rate of predicting therapy outcomes of patients with ovarian cancer. An artificial intelligence model called IRON (Integrated Radiogenomics ...
- Risk Score for Predicting Outcome in Patients With Asymptomatic Aortic Stenosis
From Assistance Publique-Hôpitaux de Paris, Department of Cardiology, Henri Mondor University Hospital, Créteil, France (J.-L.M., P.L., E.W., P.G.); Department of ...
- AI model can help predict survival outcomes for patients with cancer
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes ...
- AI model predicts patient outcomes across multiple cancer types
Out of the 24 adult cancer types, the team found that for 10 of the cancers, the clusters were associated with significant differences in patient outcomes, including progression-free survival ...
Go deeper with Google Headlines on:
Predicting depression patient outcomes
[google_news title=”” keyword=”predicting depression patient outcomes” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]